Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Epstein-Barr virus: an important vaccine target for cancer prevention.

Cohen JI, Fauci AS, Varmus H, Nabel GJ.

Sci Transl Med. 2011 Nov 2;3(107):107fs7. doi: 10.1126/scitranslmed.3002878.

2.

Progress, prospects, and problems in Epstein-Barr virus vaccine development.

Balfour HH Jr.

Curr Opin Virol. 2014 Jun;6:1-5. doi: 10.1016/j.coviro.2014.02.005. Epub 2014 Mar 15. Review.

3.

The need and challenges for development of an Epstein-Barr virus vaccine.

Cohen JI, Mocarski ES, Raab-Traub N, Corey L, Nabel GJ.

Vaccine. 2013 Apr 18;31 Suppl 2:B194-6. doi: 10.1016/j.vaccine.2012.09.041. Review.

4.

EBV conference establishes goals for defining disease-related EBV subtypes for vaccine development.

Goodman L.

Ai Zheng. 2009 Dec;28(12):1233-5. No abstract available.

PMID:
19958614
5.
6.

Prevention and treatment for Epstein-Barr virus infection and related cancers.

Smets F, Sokal EM.

Recent Results Cancer Res. 2014;193:173-90. doi: 10.1007/978-3-642-38965-8_10. Review.

PMID:
24008299
7.

[Epstein-Barr virus].

Tsurumi T.

Nihon Rinsho. 2003 Mar;61 Suppl 3:582-6. Review. Japanese. No abstract available.

PMID:
12718032
8.
9.

Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.

Dasari V, Bhatt KH, Smith C, Khanna R.

Expert Rev Vaccines. 2017 Apr;16(4):377-390. doi: 10.1080/14760584.2017.1293529. Epub 2017 Feb 20. Review.

PMID:
28276306
10.

Epstein-Barr virus myocarditis as the first symptom of infectious mononucleosis.

Zabala López S, Vicario JM, Lerín FJ, Fernández A, Pérez G, Fonseca C.

Intern Med. 2010;49(6):569-71. Epub 2010 Mar 15.

11.

[The clinical value of immunological markers of EBV infection in children with infectious mononucleosis].

Kurtasova LM, Ol'khovskiĭ IA, Iakunina EIu, Golovanova AE, Zablotskaia SG.

Klin Lab Diagn. 2005 Dec;(12):44-6. Russian.

PMID:
16498957
12.

Epstein-Barr virus: the first human tumor virus and its role in cancer.

Pagano JS.

Proc Assoc Am Physicians. 1999 Nov-Dec;111(6):573-80. Review.

PMID:
10591086
13.

[Epstein-Barr virus infection and its related diseases].

Zhao LQ, Qian Y.

Zhonghua Er Ke Za Zhi. 2003 Oct;41(10):797-9. Review. Chinese. No abstract available.

PMID:
14731376
14.

Infectious Mononucleosis.

Dunmire SK, Hogquist KA, Balfour HH.

Curr Top Microbiol Immunol. 2015;390(Pt 1):211-40. doi: 10.1007/978-3-319-22822-8_9. Review.

15.

Epstein-Barr virus vaccine: a cytotoxic T-cell-based approach.

Bharadwaj M, Moss DJ.

Expert Rev Vaccines. 2002 Dec;1(4):467-76. Review.

PMID:
12901585
17.

Aberrant EBV antibody patterns may mimic acute EBV infections.

Pottgiesser T, Schumacher YO, Bauer G.

Clin J Sport Med. 2009 Jan;19(1):74. doi: 10.1097/JSM.0b013e3181957dc4. No abstract available.

PMID:
19124991
18.

Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection.

Yoda K, Sata T, Kurata T, Aramaki H.

Arch Otolaryngol Head Neck Surg. 2000 Feb;126(2):185-93.

PMID:
10680870
19.

[Immunologic tests: Epstein-Barr virus].

Mizuno F.

Nihon Rinsho. 2005 Jul;63 Suppl 7:300-3. Review. Japanese. No abstract available.

PMID:
16111256
20.

Spontaneous Regression of Pulmonary Nodules Presenting as Epstein-Barr Virus-related Atypical Infectious Mononucleosis.

Shinozuka J, Awaguni H, Tanaka S, Makino S, Maruyama R, Inaba T, Imashuku S.

J Pediatr Hematol Oncol. 2016 Jul;38(5):e162-5. doi: 10.1097/MPH.0000000000000562.

PMID:
27123664

Supplemental Content

Support Center